# EDGAR Filing Document

**Accession Number:** 0001878313
**File Stem:** 0001564590-23-001798
**Filing Date:** 2023-2
**Character Count:** 2143
**Document Hash:** 87fca49502bfdbe6e7ed0d27832ffd86
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001564590-23-001798.hdr.sgml**: 20230522

**ACCESSION NUMBER**: 0001564590-23-001798

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230213

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MAIA Biotechnology, Inc.
- **CENTRAL INDEX KEY:** 0001878313
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 444 WEST LAKE STREET, SUITE 1700
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606
- **BUSINESS PHONE:** 312-416-8592

**MAIL ADDRESS:**
- **STREET 1:** 444 WEST LAKE STREET, SUITE 1700
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60606

#### MAIA Biotechnology, Inc.

#### 4444 West Lake Street, Suite 1700

#### Chicago, IL 60606
February 13, 2023

#### VIA EDGAR & TELECOPY
U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

Washington, D.C. 20549

Attention: Jimmy McNamara

---

| | |
|:---|:---|
| **RE:**  | **MAIA Biotechnology, Inc. (the "Company")** |
|  | **Registration Statement on Form S-1 (File No. 333-269606) (the "Registration Statement")**<br> **<u>Withdrawal Request for Acceleration of Effective Date</u>**<br>|

---

Ladies and Gentlemen:

Reference is made to the Company's letter, filed as correspondence via EDGAR on February 9, 2023, in which the Company requested acceleration of effectiveness of the Registration Statement on February 13, 2023 at 5:00 p.m., Eastern Time, or as soon as practicable thereafter. The Company hereby formally withdraws its request for acceleration of the effective date pursuant to the prior letter.

---

| | | |
|:---|:---|:---|
| Very truly yours,**<br>MAIA Biotechnology, Inc.** | Very truly yours,**<br>MAIA Biotechnology, Inc.** | Very truly yours,**<br>MAIA Biotechnology, Inc.** |
| By:  | /s/ Vlad Vitoc | /s/ Vlad Vitoc |
|  | Name:  | Vlad Vitoc |
|  | Title: | Chief Executive Officer |

---

cc: Angela Dowd, Esq., Loeb & Loeb LLP